Klucznik Karolina A, Ravkilde Thomas, Skouboe Simon, Møller Ditte S, Hokland Steffen, Keall Paul, Buus Simon, Bentzen Lise, Poulsen Per R
Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Phys Imaging Radiat Oncol. 2025 Jun 24;35:100798. doi: 10.1016/j.phro.2025.100798. eCollection 2025 Jul.
Intra-fractional prostate translational and rotational (6DoF) motion can cause dose distortions. As intra-fractional motion monitoring is often unavailable, this study compares three methods to use pre- and post-treatment cone beam CTs (CBCT) to estimate prostate positioning errors during treatment and their dosimetric impact.
Eighteen patients received prostate radiotherapy with pre-treatment CBCT setup. For 7-10 fractions per patient (total:174), triggered kV-images were acquired every 3 s during beam-on and a CBCT was acquired post-treatment. The 6DoF prostate position error during treatment was determined from the kV-images (ground truth) and estimated from the CBCTs assuming a static position as in the pre-CBCT(Scenario1), a linear drift between pre- and post-CBCT position(Scenario2) or a static position as in the post-CBCT(Scenario3). The positioning errors and prostate dose from each scenario were compared with the ground truth.
Scenario1 was inferior to the others with prostate position root-mean-square errors of 1.1 mm(LR), 1.7 mm(AP) and 1.8 mm(CC). Scenario2 and 3 were similarly accurate with root-mean-square errors of 0.5 mm(LR), 0.9 mm(AP) and 0.8 mm(CC) (Scenario2) and 0.6 mm(LR), 1.1 mm(AP) and 0.9 mm(CC) (Scenario3). The prostate position errors reduced the CTV D by more than 2/3 % at 24/15 % of the fractions, respectively. The sensitivity in detecting these dose deficits was low for Scenario1 (9-16 %) and considerably higher for Scenario2 (68-76 %) and Scenario3 (86-91 %). All scenarios showed high specificity (93-99 %).
Using the post-CBCT prostate position, acquired right after treatment, performed best in detecting intra-fractional prostate position errors and CTV dose deficits. It offers a scalable and conservative estimate of motion-induced dose distortions.
分次治疗期间前列腺的平移和旋转(6自由度)运动会导致剂量畸变。由于通常无法进行分次治疗期间的运动监测,本研究比较了三种利用治疗前和治疗后锥束CT(CBCT)来估计治疗期间前列腺定位误差及其剂量学影响的方法。
18例患者接受了基于治疗前CBCT设置的前列腺放疗。每位患者进行7 - 10次分次治疗(共174次),在射束开启期间每3秒采集一次触发千伏图像,并在治疗后采集一次CBCT。治疗期间的6自由度前列腺位置误差由千伏图像确定(真实情况),并根据CBCT估计,假设为CBCT前的静态位置(方案1)、CBCT前后位置的线性漂移(方案2)或CBCT后的静态位置(方案3)。将每种方案的定位误差和前列腺剂量与真实情况进行比较。
方案1不如其他方案,前列腺位置的均方根误差为左右方向(LR)1.1毫米、前后方向(AP)1.7毫米和头脚方向(CC)1.8毫米。方案2和方案3同样准确,均方根误差分别为左右方向0.5毫米、前后方向0.9毫米和头脚方向0.8毫米(方案2)以及左右方向0.6毫米、前后方向1.1毫米和头脚方向0.9毫米(方案3)。前列腺位置误差分别在24%/15%的分次治疗中使临床靶体积(CTV)剂量降低超过2/3%。方案1检测这些剂量不足的敏感性较低(9 - 16%),而方案2(68 - 76%)和方案3(86 - 91%)的敏感性则高得多。所有方案均显示出高特异性(93 - 99%)。
使用治疗后立即采集的CBCT前列腺位置,在检测分次治疗期间前列腺位置误差和CTV剂量不足方面表现最佳。它提供了一种可扩展且保守的运动诱导剂量畸变估计。